Serine-arginine-rich protein kinase-1 inhibition for the treatment of diabetic retinopathy.

Saved in:

Bibliographic Details
Title:	Serine-arginine-rich protein kinase-1 inhibition for the treatment of diabetic retinopathy.
Authors:	Malhi NK; Tumour and Vascular Biology Laboratories, Division of Cancer and Stem Cells, Centre for Cancer Sciences, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom., Allen CL; Tumour and Vascular Biology Laboratories, Division of Cancer and Stem Cells, Centre for Cancer Sciences, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom., Stewart E; Exonate Limited, Duxford, United Kingdom., Horton KL; Tumour and Vascular Biology Laboratories, Division of Cancer and Stem Cells, Centre for Cancer Sciences, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom., Riu F; Tumour and Vascular Biology Laboratories, Division of Cancer and Stem Cells, Centre for Cancer Sciences, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom., Batson J; Exonate Limited, Duxford, United Kingdom., Amoaku W; Division of Clinical Neuroscience, Department of Ophthalmology, School of Medicine, University of Nottingham, Nottingham, United Kingdom., Morris JC; School of Chemistry, University of New South Wales, Sydney, New South Wales, Australia., Arkill KP; Tumour and Vascular Biology Laboratories, Division of Cancer and Stem Cells, Centre for Cancer Sciences, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom., Bates DO; Tumour and Vascular Biology Laboratories, Division of Cancer and Stem Cells, Centre for Cancer Sciences, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom.; Exonate Limited, Duxford, United Kingdom.; COMPARE, University of Birmingham and University of Nottingham Midlands, Nottingham, United Kingdom.
Source:	American journal of physiology. Heart and circulatory physiology [Am J Physiol Heart Circ Physiol] 2022 Jun 01; Vol. 322 (6), pp. H1014-H1027. Date of Electronic Publication: 2022 Mar 18.
Publication Type:	Journal Article; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: American Physiological Society Country of Publication: United States NLM ID: 100901228 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-1539 (Electronic) Linking ISSN: 03636135 NLM ISO Abbreviation: Am J Physiol Heart Circ Physiol Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1522-1539
DOI:	10.1152/ajpheart.00001.2022